Literature DB >> 23402990

Oxygen therapy in preterm infants.

S Cherian1, I Morris1, J Evans1, S Kotecha2.   

Abstract

Despite being the most widely used and vital therapy in neonatology, optimal strategies for the use of oxygen in preterm infants remain controversial. Achieving the balance between attaining adequate tissue oxygenation and avoiding oxygen toxicity is challenging. There remains a paucity of clear evidence based guidance for clinicians on safe oxygen saturation targets. What does seem apparent is that these targets vary over time in the life of a preterm infant. This article summarises the evidence behind current practice of oxygen monitoring and administration from the first few minutes after birth, through to the acute neonatal and later convalescent periods. Finally, we review the use of home oxygen for preterm infants with bronchopulmonary dysplasia including administration and weaning from domically home oxygen.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Continuous positive airway pressure (CPAP); Domiciliary oxygen; High flow oxygen, Neonatal resuscitation; Oxygen saturation monitoring; Preterm, Oxygen therapy

Mesh:

Substances:

Year:  2013        PMID: 23402990     DOI: 10.1016/j.prrv.2012.12.003

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  9 in total

Review 1.  The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela.

Authors:  Theodore Bowe; Lily Nyamai; Dupe Ademola-Popoola; Atchara Amphornphruet; Rachelle Anzures; Linda A Cernichiaro-Espinosa; Roseline Duke; Fahir Duran; Maria Ana Martinez-Castellanos; Prabhujot Kaur Multani; Cristina E Nitulescu; Tapas Ranjan Padhi; Boontip Tipsuriyaporn; R V Paul Chan; J Peter Campbell; Yoshihiro Yonekawa
Journal:  Digit J Ophthalmol       Date:  2019-10-12

2.  Lung Disease, Oxidative Stress, and Oxygen Requirements in Preterm Infants.

Authors:  Tiffany A Moore; Kendra K Schmid; Ann Anderson-Berry; Ann M Berger
Journal:  Biol Res Nurs       Date:  2015-10-27       Impact factor: 2.522

3.  Characteristics of home oxygen therapy for preterm infants with bronchopulmonary dysplasia in China: results of a multicenter cohort study.

Authors:  Wen-Xing Jiang; Yan-Chen Wang; Hong-Xia Song; Mi Xiao; Fan He; Si-Yuan Jiang; Xin-Yue Gu; Jian-Hua Sun; Yun Cao; Wen-Hao Zhou; Shoo Kim Lee; Li-Ping Chen; Li-Yuan Hu
Journal:  World J Pediatr       Date:  2022-08-11       Impact factor: 9.186

4.  Hydrogen sulfide, oxygen, and calcium regulation in developing human airway smooth muscle.

Authors:  Colleen M Bartman; Marta Schiliro; Martin Helan; Y S Prakash; David Linden; Christina Pabelick
Journal:  FASEB J       Date:  2020-08-10       Impact factor: 5.191

5.  Cellular clocks in hyperoxia effects on [Ca2+]i regulation in developing human airway smooth muscle.

Authors:  Colleen M Bartman; Aleksey Matveyenko; Christina Pabelick; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-01-06       Impact factor: 5.464

6.  High-Flow Nasal Cannula versus Conventional Oxygen Therapy in Children with Respiratory Distress.

Authors:  Punthila Sitthikarnkha; Rujipat Samransamruajkit; Nuanchan Prapphal; Jitladda Deerojanawong; Suchada Sritippayawan
Journal:  Indian J Crit Care Med       Date:  2018-05

7.  Proximal Tubular Development Is Impaired with Downregulation of MAPK/ERK Signaling, HIF-1α, and Catalase by Hyperoxia Exposure in Neonatal Rats.

Authors:  Xuewen Xu; Kai You; Renge Bu
Journal:  Oxid Med Cell Longev       Date:  2019-08-28       Impact factor: 6.543

8.  Neonatal Hyperoxia Downregulates Claudin-4, Occludin, and ZO-1 Expression in Rat Kidney Accompanied by Impaired Proximal Tubular Development.

Authors:  Xuewen Xu; Xinyue Zhang; Linlin Gao; Chunfeng Liu; Kai You
Journal:  Oxid Med Cell Longev       Date:  2020-12-02       Impact factor: 6.543

9.  Haem relieves hyperoxia-mediated inhibition of HMEC-1 cell proliferation, migration and angiogenesis by inhibiting BACH1 expression.

Authors:  Lan Jian; Yang Mei; Chen Xing; Yuan Rongdi
Journal:  BMC Ophthalmol       Date:  2021-02-25       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.